Fraunhofer scientists present first results of the development of a new sterilization technology and a highly effective hygiene safety process for the preparation of aseptically packed medical products within the project SteriHealth®.
Medical technology is one of the sectors within the fields of technology and research with a rising demand for innovations and a high dynamic of research and development. The increasing complexity of disease patterns, the rising life expectancy and the high pressure for rationalization in the healthcare sector offer good future opportunities for companies in field of medical technology, but at the same time imply a lot of risks.
Some of the major risk factors of medical treatment are postoperative and nosocomial infections. The necessary funds which are required for these factors are estimated up to 1 – 2 billion Euro per year. A result of this is an increasing social and political pressure.
A significant solution for the minimization of infection risks are safe, flexible and quick hygiene protection processes. Especially thermolabile microsystems, instruments or implants with intelligent sensors and cell-therapeutic products are problematic so far.
To minimize the deficides of the common processes the Fraunhofer Institutes FEP, IBMT, ITEM, IVV, IVV Dresden and IZI worked on the development of a highly effective hygiene safety process for the processing of aseptically packed medical products for hospitals, medical offices and geriatric care facilities within the Fraunhofer-funded project SteriHealth®. The key part of the joint project was the the transdisciplinary development of a technology for the miniaturization of the common beamsterilization based on the gentle, but highly effective low-energy electron-beam technology in order to enable an on-site sterilization within a few seconds.
“Once more this project demonstrates, that Fraunhofer Institutes with very different expertise are in able to solve highly complex questions by concentrating their professional competence successfully. The consortium had to face a number of sophisticated challenges, e.g. the development of technology, qualification of the packaging material, the development of a monitoring system as well as the evaluation of the efficiency of the sterilization. My special thanks goes to the members of the consulting board, who enriched the project with their expertise during the whole term of 3.5 years”, states the leading project manager Dr. Axel Wibbertmann of Fraunhofer ITEM.
The next aim of the consortium of SteriHealth® is the finalization of the Mini-Sterilizer. “Therefore we offer the opportunity to interested partners from industry to cooperate with us and to participate with their competence and market entry in this field. At the same time we hope for the support from politics and funding partners for this sensitive topic”, Frank-Holm Rögner, project leader at Fraunhofer FEP looks ahead.
The consortium cordially invites you to join the workshop SteriHealth® “New Possibilities for Effective On-Site-Sterilization” on February 3rd, 2015. The workshop will be held in German language and the project achievements and the demonstrator will be presented. The workshop will be a platform for further discussions and exchange of ideas.
Further information about the project SteriHealth® can be found at:
We would be pleased to welcoming you in Dresden!
Organic Electronics, Electron Beam and Plasma Technology FEP| Phone +49 351 2586 452 | Annett.Arnold@fep.fraunhofer.de
Winterbergstraße 28 | 01277 Dresden | Germany | www.fep.fraunhofer.de
Annett Arnold | Fraunhofer-Institut
New insight into the brain’s hidden depths: Jena scientists develop minimally-invasive endoscope
27.11.2018 | Leibniz-Institut für Photonische Technologien e. V.
New China and US studies back use of pulse oximeters for assessing blood pressure
21.11.2018 | University of British Columbia
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Awards Funding
13.12.2018 | Earth Sciences
13.12.2018 | Materials Sciences